Revascularization Strategies in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Coronary Disease.
暂无分享,去创建一个
I. Kardys | F. Zijlstra | R. Diletti | P. D. de Jaegere | N. Van Mieghem | J. Daemen | K. Ameloot | L. V. van Zandvoort | W. D. den Dekker | K. Masdjedi | M. Balbi | J. Wilschut | P. Scarparo | M. N. Tovar Forero | Miguel Lemmert
[1] Á. Avezum,et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2019, The New England journal of medicine.
[2] Yaiza Beatriz Molero-Díez,et al. Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.
[3] D. Erlinge,et al. Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial. , 2018, JACC. Cardiovascular interventions.
[4] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.
[5] J. Spertus,et al. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document , 2018, Circulation.
[6] G. Hindricks,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.
[7] K. Choi,et al. Prognosis of deferred non-culprit lesions according to fractional flow reserve in patients with acute coronary syndrome. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[8] G. Stefanini,et al. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. , 2017, The New England journal of medicine.
[9] F. Neumann,et al. Fractional Flow Reserve‐Guided Multivessel Angioplasty in Myocardial Infarction , 2017, The New England journal of medicine.
[10] Deepak L. Bhatt,et al. Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials. , 2017, JACC. Cardiovascular interventions.
[11] S. Robinson,et al. Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease. , 2017, JACC. Cardiovascular interventions.
[12] L. Køber,et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial , 2015, The Lancet.
[13] S. Bangalore,et al. Complete Versus Culprit-Only Revascularization for ST-Segment–Elevation Myocardial Infarction and Multivessel Disease: A Meta-Analysis and Trial Sequential Analysis of Randomized Trials , 2015, Circulation. Cardiovascular interventions.
[14] H. Swanton,et al. Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease , 2015, Journal of the American College of Cardiology.
[15] R. Califf,et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. , 2014, JAMA.
[16] M. Valgimigli,et al. CORONARY ARTERY DISEASE Original Studies Long-Term Outcome in Patients with ST Segment Elevation Myocardial Infarction and Multivessel Disease Treated with Culprit-Only, Immediate, or Staged Multivessel Percutaneous Revascularization Strategies: Insights from the REAL Registry , 2014 .
[17] C. Berry,et al. Randomized trial of preventive angioplasty in myocardial infarction. , 2013, The New England journal of medicine.
[18] C. Terkelsen,et al. Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[19] B. Gersh,et al. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2011, Journal of the American College of Cardiology.
[20] Hiroto Tsujioka,et al. Multiple coronary lesion instability in patients with acute myocardial infarction as determined by optical coherence tomography. , 2010, The American journal of cardiology.
[21] J. Hartikainen,et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries , 2009, European heart journal.
[22] Seung‐Jung Park,et al. A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris. , 2008, The American journal of cardiology.
[23] B. Gersh,et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. , 2007, European heart journal.
[24] A. J. O’Malley,et al. Effects of stent length and lesion length on coronary restenosis. , 2004, The American journal of cardiology.
[25] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials , 2003, The Lancet.
[26] M. Hori,et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. , 2001, Journal of the American College of Cardiology.
[27] K. Lee,et al. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. , 1991, American heart journal.
[28] Pim A. L. Tonino,et al. Study : Fractional Flow Reserve Versus Angiography in Multivessel Angiographic Versus Functional Severity of Coronary Artery Stenoses in the , 2010 .